Skip to main content
Some text as placeholder. In real life you can have the elements you have chosen. Like, text, images, lists, etc.
What are you looking for?

What to Expect on Drug Pricing in the Democratic Trifecta


President Joe Biden hit the ground running, signing 30 executive orders on healthcare. We can expect the focus on healthcare to continue, including speeding up vaccinations across the country and passing a new stimulus package as the first order of legislative business. Lowering drug prices will also remain a hot topic.


However, the more ambitious policies touted during the campaign, such as allowing Medicare to negotiate directly with pharmaceutical manufacturers, will likely be put on ice given the extremely narrow majorities held by the Democratic party in both chambers of
Congress. A few legislative and regulatory proposals will remain a risk for the pharmaceutical industry. Download the article below to learn what to watch for. 


To download the free whitepaper, fill out the form below:

Interested in Syneos Health?